18,000 CVS Health Corporation $CVS Shares Purchased by Consolidated Investment Group LLC

Consolidated Investment Group LLC lifted its position in CVS Health Corporation (NYSE:CVS) by 85.7% in the third quarter, Holdings Channel reports. The firm owned 39,000 shares of the pharmacy operator’s stock after buying an additional 18,000 shares during the period. Consolidated Investment Group LLC’s holdings in CVS Health were worth $3,342,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. BlackRock Inc. purchased a new position in CVS Health during the 2nd quarter worth $12,747,462,000. State Street Corp raised its position in CVS Health by 26.3% during the 2nd quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator’s stock valued at $7,751,205,000 after purchasing an additional 15,604,883 shares in the last quarter. Bank of America Corp DE lifted its holdings in shares of CVS Health by 148.0% in the 2nd quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock worth $2,398,868,000 after buying an additional 13,836,701 shares during the period. Pzena Investment Management LLC bought a new position in shares of CVS Health during the 2nd quarter worth $1,217,558,000. Finally, Wellington Management Group LLP increased its stake in shares of CVS Health by 49.8% during the second quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock valued at $3,496,725,000 after buying an additional 11,233,381 shares during the period. Institutional investors own 80.66% of the company’s stock.

Insider Transactions at CVS Health

In related news, EVP Prem Shah bought 23,855 shares of the business’s stock in a transaction on Friday, November 6th. The shares were bought at an average price of $83.89 per share, for a total transaction of $2,001,195.95. Following the completion of the purchase, the executive vice president directly owned 88,516 shares of the company’s stock, valued at approximately $7,425,607.24. This trade represents a 36.89% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.85% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on CVS. Weiss Ratings downgraded CVS Health from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, October 9th. TD Cowen reiterated a “buy” rating on shares of CVS Health in a report on Wednesday, November 4th. Barclays cut their target price on shares of CVS Health from $108.00 to $107.00 and set an “overweight” rating on the stock in a research report on Thursday, November 5th. Raymond James Financial set a $103.00 price target on shares of CVS Health in a report on Friday. Finally, UBS Group reduced their price target on shares of CVS Health from $118.00 to $107.00 and set a “buy” rating for the company in a report on Thursday, November 5th. Twenty-two equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $108.25.

CVS Health Stock Up 1.6%

Shares of NYSE CVS opened at $85.16 on Tuesday. The company has a current ratio of 0.85, a quick ratio of 0.66 and a debt-to-equity ratio of 0.71. The stock has a market capitalization of $108.92 billion, a PE ratio of 9.60, a price-to-earnings-growth ratio of 0.73 and a beta of 0.58. The stock’s fifty day simple moving average is $90.21 and its two-hundred day simple moving average is $88.91. CVS Health Corporation has a 12-month low of $69.51 and a 12-month high of $110.68.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.65 by $0.44. The business had revenue of $108.40 billion for the quarter, compared to the consensus estimate of $104.72 billion. CVS Health had a return on equity of 13.65% and a net margin of 2.62%. The business’s revenue was up 5.4% compared to the same quarter last year. During the same period last year, the business posted $1.60 EPS. As a group, analysts expect that CVS Health Corporation will post 8.25 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, November 2nd. Investors of record on Thursday, October 22nd were given a dividend of $0.6650 per share. The ex-dividend date of this dividend was Thursday, October 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.1%. CVS Health’s dividend payout ratio (DPR) is presently 30.97%.

CVS Health News Roundup

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: An executive bought about $2 million of CVS stock, a notable insider purchase that may signal confidence in the company’s outlook. Insider Buying: CVS Health EVP Buys $2,001,195.95 in Stock
• Positive Sentiment: CVS’s latest quarter beat analyst estimates for earnings and revenue. Management cited pharmacy strength, progress in Medicare margin recovery, improvement in its medical benefit ratio and solid cash generation—supportive signs for its operating outlook. The top 5 analyst questions from CVS Health’s Q3 2026 earnings call
• Neutral Sentiment: CVS’s planned separation into two entities is being framed as potentially beneficial to shareholders, but Mark Cuban argued it would do little for patients and called for legislation targeting healthcare monopolies. The breakup’s financial benefits remain a key investor question. Mark Cuban on the CVS breakup
• Neutral Sentiment: A reported $2.1 million settlement is small relative to CVS’s scale, so its direct financial impact appears limited. CVS settlement will see $2.1 million paid out
• Negative Sentiment: CVS is challenging Tennessee’s law barring pharmacies from owning pharmacy benefit managers. The dispute adds regulatory uncertainty around its integrated business model, even as the company says pharmacy services will continue uninterrupted. CVS Health challenges Tennessee PBM ownership ban in federal court

About CVS Health

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division.

The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Founded in 1963 as Consumer Value Stores in Lowell, Massachusetts, the company expanded from a retail pharmacy business into a broad health care organization and adopted the CVS Health name in 2014.